Mild Cognitive Impairment
Welcome,         Profile    Billing    Logout  
 21 Companies   27 Products   27 Products   9 Mechanisms of Action   1 Trial   379 News 


«12345678»
  • ||||||||||  Biomarker, Trial completion:  Functional MRI Biomarkers of Cognitive Decrements in Diabetes (clinicaltrials.gov) -  Apr 10, 2015   
    P=N/A,  N=106, Completed, 
    Trial primary completion date: Jun 2015 --> Dec 2015 Recruiting --> Completed
  • ||||||||||  Enrollment closed:  Retaining Cognition While Avoiding Late-Life Depression (clinicaltrials.gov) -  Apr 6, 2015   
    P=N/A,  N=136, Active, not recruiting, 
    Recruiting --> Completed Recruiting --> Active, not recruiting
  • ||||||||||  Trial completion, Enrollment change:  Mild Cognitive Impairment and Obstructive Sleep Apnea (clinicaltrials.gov) -  Mar 17, 2015   
    P3,  N=86, Completed, 
    Recruiting --> Active, not recruiting Recruiting --> Completed | N=110 --> 86
  • ||||||||||  Enrollment change, Trial termination, Trial primary completion date, FDG PET:  Early Diagnosis of Alzheimer-like Dementia: Benefit of MRI and PET Imaging (clinicaltrials.gov) -  Mar 10, 2015   
    P=N/A,  N=60, Terminated, 
    N=350 --> 60 | Suspended --> Terminated | Trial primary completion date: Jul 2014 --> Apr 2013; Administrative re-organization of the department. Referent physician left the hospital.
  • ||||||||||  Kisunla (donanemab-azbt) / Eli Lilly
    Enrollment closed:  A Study of LY3002813 in Participants With Alzheimer's Disease (clinicaltrials.gov) -  Feb 27, 2015   
    P1,  N=100, Active, not recruiting, 
    Referent physician left the hospital. Recruiting --> Active, not recruiting
  • ||||||||||  rivastigmine transdermal / Generic mfg.
    Trial completion:  Mild Cognitive Impairment in Parkinson's Disease (clinicaltrials.gov) -  Feb 27, 2015   
    P4,  N=28, Completed, 
    Recruiting --> Active, not recruiting Recruiting --> Completed
  • ||||||||||  TTP4000 / vTv Therapeutics
    Trial completion, Enrollment change, Trial primary completion date:  A Safety Study of TTP4000 in Subjects With Alzheimer's Disease (clinicaltrials.gov) -  Feb 12, 2015   
    P1,  N=8, Completed, 
    Trial primary completion date: Mar 2015 --> Dec 2015 Active, not recruiting --> Completed | N=16 --> 8 | Trial primary completion date: Sep 2012 --> Feb 2013
  • ||||||||||  midodrine hydrochloride / Generic mfg.
    Enrollment closed, Trial primary completion date:  Body Temperature in Persons With Tetraplegia When Exposed to Cold (clinicaltrials.gov) -  Feb 5, 2015   
    P4,  N=30, Active, not recruiting, 
    Recruiting --> Active, not recruiting | Trial primary completion date: Dec 2014 --> Dec 2015 Recruiting --> Active, not recruiting | Trial primary completion date: Mar 2014 --> Feb 2015
  • ||||||||||  Trial primary completion date:  Postoperative Cognitive Decline, Inflammation, and Plasma Levels of Beta-amyloids (clinicaltrials.gov) -  Jan 28, 2015   
    P=N/A,  N=50, Active, not recruiting, 
    Recruiting --> Active, not recruiting | Trial primary completion date: Mar 2014 --> Feb 2015 Trial primary completion date: Jul 2014 --> Jul 2015
  • ||||||||||  Trial primary completion date, Combination therapy:  Effects of Dietary Interventions on the Brain in Mild Cognitive Impairment (MCI) (clinicaltrials.gov) -  Jan 22, 2015   
    P4,  N=330, Recruiting, 
    Recruiting --> Active, not recruiting | Trial primary completion date: Dec 2014 --> Mar 2015 Trial primary completion date: Jul 2014 --> Jul 2015
  • ||||||||||  Kisunla (donanemab-azbt) / Eli Lilly
    Trial primary completion date:  A Study of LY3002813 in Participants With Alzheimer's Disease (clinicaltrials.gov) -  Dec 19, 2014   
    P1,  N=100, Recruiting, 
    N=400 --> 300 | Trial primary completion date: Sep 2014 --> Sep 2016 Trial primary completion date: May 2015 --> Aug 2015
  • ||||||||||  Trial primary completion date:  Cognitive Impairment and Balance in Elderly (clinicaltrials.gov) -  Dec 10, 2014   
    P=N/A,  N=100, Recruiting, 
    Recruiting --> Completed Trial primary completion date: Oct 2014 --> Jan 2015
  • ||||||||||  Trial completion, Trial primary completion date:  A Rehabilitation Intervention for Amnestic Mild Cognitive Impairment (clinicaltrials.gov) -  Dec 7, 2014   
    P=N/A,  N=128, Completed, 
    Trial primary completion date: Sep 2014 --> May 2016 Active, not recruiting --> Completed | Trial primary completion date: Apr 2014 --> Aug 2013
  • ||||||||||  citalopram / Generic mfg., venlafaxine / Generic mfg., donepezil / Generic mfg.
    Trial primary completion date:  DEP-CI: Combination Treatment Study for Memory Impairment and Depression (clinicaltrials.gov) -  Sep 28, 2014   
    P4,  N=80, Recruiting, 
    Recruiting --> Completed Trial primary completion date: Aug 2014 --> Mar 2015
  • ||||||||||  minocycline / Generic mfg.
    Trial completion, Enrollment change:  Minocycline in Patients With Alzheimer's Disease (clinicaltrials.gov) -  Sep 28, 2014   
    P2,  N=13, Completed, 
    Trial primary completion date: Aug 2014 --> Mar 2015 Recruiting --> Completed | N=120 --> 13
  • ||||||||||  Trial completion:  HBA: Home-Based Assessment for Alzheimer Disease Prevention (clinicaltrials.gov) -  Sep 16, 2014   
    P=N/A,  N=640, Completed, 
    Recruiting --> Completed | N=120 --> 13 Active, not recruiting --> Completed
  • ||||||||||  Enrollment closed:  Shanghai Mild Cognitive Impairment Cohort Study (clinicaltrials.gov) -  Sep 11, 2014   
    P=N/A,  N=400, Active, not recruiting, 
    Active, not recruiting --> Completed Recruiting --> Active, not recruiting